Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 70518-3298 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is a description of Atorvastatin Calcium with NDC code 70518-3208-00, manufactured by Novadoz Pharmaceuticals LLC. It comes in tablet form with 10mg strength and a quantity of 30. The lot number and source NDC are provided, along with storage instructions stating it should be kept between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F). It is advised to keep this medication away from children. Directions for use are found in the package insert. This medication has been repackaged by RemedyRepack Inc. and is for RX use only.*

figure-01 - atorvastatin figure 01

figure-01 - atorvastatin figure 01

figure-02 - atorvastatin figure 02

figure-02 - atorvastatin figure 02

The text appears to be a graph showing the cumulative hazard percentage, with data points labeled as "1517" and "10 7". It also includes a hazard ratio with confidence interval and p-value. The graph displays the time to the first primary endpoint through four years of follow-up. No additional information is available to provide further context or explanation of the data.*

figure-03 - atorvastatin figure 03

figure-03 - atorvastatin figure 03

This is a clinical trial result for the use of Atorvastatin at doses of 10mg and 80mg in decreasing the risk of major cardiovascular events in a group of subjects. The numbers represent the percentages of subjects experiencing such events at different time points. Atorvastatin 80mg was found to be statistically significant in reducing the risk of such events compared to the placebo group (HR0.78, P=0.0002).*

structure - atorvastatin structure

structure - atorvastatin structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.